Wednesday Pre-Market Top Gainers $NVCN $SIOX $BLRX

Alex Winkler

winkler
watchlist
Dec. 16, 2020, midnight
Aug. 1, 2022, 8:08 p.m.
$25k Challenge, Swing Trading Momo, Day Trading Momo,

submit to reddit

News

USA Corona Virus

Live Stream

https://youtu.be/xNgaIee4IeU

Research / Recap Video

Well, that was a hectic stream. Here's a proper Mid-Day Recap & Full Analysis of our swing portfolio!

https://youtu.be/CY935cp_yoM

Watchlist

NVCN [NASD]

Neovasc Inc.

Healthcare | Medical Devices | Canada

55% 18mc 15f

Dec-15-20 04:33PM	ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Neovasc Inc. Investors of Important January 5 Deadline in Securities Class Action - NVCN Newsfile +6.47%
01:00PM	ICPT & NVCN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
11:00AM	DEADLINE ALERT for HPQ, ICPT, and NVCN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
07:52AM	The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga
07:00AM	Neovasc Announces First Neovasc Reducer(TM) Implants in France Newsfile
07:00AM	Neovasc Announces First Neovasc Reducer Implants in France GlobeNewswire
Dec-14-20 09:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Neovasc Inc. of Class Action Lawsuit and Upcoming Deadline - NVCN Newsfile
06:40PM	Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Newsfile
06:28PM	Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency GlobeNewswire
01:00PM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Neovasc Inc. (NVCN) GlobeNewswire

SIOX [NASD]

Sio Gene Therapies, Inc.

Healthcare | Biotechnology | USA

40% 134mc 30f

Dec-15-20 04:01PM	Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis GlobeNewswire +15.45%
Dec-02-20 07:00AM	Sio Gene Therapies Announces First Patient Dosed in High-Dose Cohort of AXO-AAV-GM1 Clinical Trial in Patients with GM1 Gangliosidosis GlobeNewswire +15.09%

TLRY [NASD]

Tilray, Inc.

Healthcare | Drug Manufacturers - Specialty & Generic | Canada

25% 1Bmc 57f

Dec-16-20 06:43AM	Dow Jones Futures Rise As Coronavirus Stimulus Deal Expected 'Soon'; Apple Hits New Buy Point Investor's Business Daily
05:39AM	Tilray, Aphria, Wish IPO, Federal Reserve - 5 Things You Must Know Wednesday TheStreet.com
Dec-15-20 10:25PM	Tesla Fated For Similar Downfall As Tilray, Stock To Hit $60-$80 Levels In 2021, Says Long-Term Bear Benzinga +6.78%
09:21PM	Report: Tilray and Aphria in "Advanced" Merger Talks; Announcement Could Come This Week Motley Fool

AEMD [NASD]

Aethlon Medical, Inc.

Healthcare | Medical Devices | USA

77% 20mc 12f

Dec-16-20 08:02AM

Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer

PR Newswire

Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull

Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save

Watchlist 👉👉 https://tradejournal.co/post/wednesday-pre-market-top-gainers-nvcn-siox-blrx/

Buy Cash App accounts

pexaga3447

Portfolio(s): none

Posted on Oct. 2, 2024, 9:17 a.m.

Boost Your Online Presence: Buy Facebook Reviews Now!

lily117632

Portfolio(s): none

Posted on Aug. 29, 2024, 8:18 a.m.

Buy Verified Binance Account

macog42950

Portfolio(s): none

Posted on Oct. 26, 2024, 5:13 p.m.

Back to the post list ⋅ 0 comments have been posted.

Please login to comment.

// Trigger Modal After 5 Seconds & Check For localStorage to see if it's shown the popup in the last 60min